InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.020
-0.100 (-4.72%)
At close: Aug 20, 2026, 4:00 PM EDT
2.012
-0.008 (-0.38%)
After-hours: Aug 20, 2026, 7:30 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $297.68 million as of August 20, 2026. Its market cap has increased by 398.13% in one year.
Market Cap
297.68M
Enterprise Value
117.54M
1-Year Change
398.13%
Ranking
Category
Stock Price
$2.02
ChartMarket Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $297.68M, a decrease of -15.28%. That is a compound annual growth rate of -1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 297.68M | 335.05% |
| Dec 31, 2025 | 68.42M | -52.95% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 312.37M |
| Cartesian Therapeutics | 309.51M |
| Bicycle Therapeutics | 296.77M |
| Fulcrum Therapeutics | 293.74M |
| Fate Therapeutics | 293.56M |
| Anavex Life Sciences | 290.06M |
| Eledon Pharmaceuticals | 286.32M |
| Neumora Therapeutics | 284.66M |